MERIDIAN BIOSCIENCE INC 4 SEC Filings

Filed On	Filing
31 Jan 2023	Form 4: Williams Felicia, Director Returned 10,274 shares to the issuer · Disposed of 49,397 Stock Option (Right to Buy) (Disposition to Issuer) ($928K)
31 Jan 2023	Form 4: Sazdanoff Catherine, Director Returned 16,424 shares to the issuer · Disposed of 78,397 Stock Option (Right to Buy) (Disposition to Issuer) ($1.44M)
31 Jan 2023	Form 4: Rice John McCune Jr., Director Returned 27,449 shares to the issuer · Disposed of 32,192 Stock Option (Right to Buy) (Disposition to Issuer) ($511K)
31 Jan 2023	Form 4: McIlwraith John, Director Returned 21,724 shares to the issuer · Disposed of 76,397 Stock Option (Right to Buy) (Disposition to Issuer) ($1.39M)
31 Jan 2023	Form 4: Ellingwood Dwight E, Director Returned 17,290 shares to the issuer · Disposed of 82,897 Stock Option (Right to Buy) (Disposition to Issuer) ($1.48M)
31 Jan 2023	Form 4: Bihl Anthony P Iii, Director Returned 15,408 shares to the issuer · Disposed of 16,047 Stock Option (Right to Buy) (Disposition to Issuer) ($196K)
31 Jan 2023	Form 4: Anderson James M., Director Returned 33,224 shares to the issuer · Disposed of 86,897 Stock Option (Right to Buy) (Disposition to Issuer) ($1.51M)
31 Jan 2023	Form 4: Kenny John P., Director Received 47,060 shares as a grant or award · Returned 267,651 shares to the issuer · Disposed of 232,514 Stock Option (Right to Buy) (Disposition to Issuer) ($4.13M)
31 Jan 2023	Form 4: Kitzmiller Andrew S., Executive Vice President & CFO Received 7,945 shares as a grant or award · Returned 19,473 shares to the issuer · Disposed of 5,000 Stock Option (Right to Buy) (Disposition to Issuer) ($46.3K)
31 Jan 2023	Form 4: Weltzien Lourdes, Executive VP, Life Science Received 7,945 shares as a grant or award · Returned 86,045 shares to the issuer · Disposed of 36,276 Stock Option (Right to Buy) (Disposition to Issuer) ($557K)
31 Jan 2023	Form 4: Serafini-Lamanna Tony, Executive VP-Diagnostics Received 7,945 shares as a grant or award · Returned 43,338 shares to the issuer · Disposed of 37,776 Stock Option (Right to Buy) (Disposition to Issuer) ($666K)
31 Jan 2023	Form 4: Smith Julie Diana, Sr VP, Controller, PAO Received 2,648 shares as a grant or award · Returned 58,308 shares to the issuer · Disposed of 2,000 Stock Option (Right to Buy) (Disposition to Issuer) ($54.1K)
09 Jan 2023	Form 4: Anderson James M., Director Received 8,500 shares by exercise or conversion ($173K)
07 Dec 2022	Form 4: Smith Julie Diana, Sr VP, Controller, PAO Gave up 374 shares to cover exercise price or tax ($11.9K)
17 Nov 2022	Form 4: Smith Julie Diana, Sr VP, Controller, PAO Gave up 1,845 shares to cover exercise price or tax ($58.7K)
17 Nov 2022	Form 4: Serafini-Lamanna Tony, Executive VP-Diagnostics Gave up 3,666 shares to cover exercise price or tax ($117K)
17 Nov 2022	Form 4: Weltzien Lourdes, EVP, Life Science Gave up 4,382 shares to cover exercise price or tax ($139K)
08 Nov 2022	Form 4: Smith Julie Diana, Sr VP, Controller, PAO Gave up 397 shares to cover exercise price or tax ($12.7K)
08 Nov 2022	Form 4: Weltzien Lourdes, EVP, Life Science Gave up 566 shares to cover exercise price or tax ($18.1K)
08 Nov 2022	Form 4: Serafini-Lamanna Tony, Executive VP-Diagnostics Gave up 788 shares to cover exercise price or tax ($25.2K)

Comments